VPC
ABVX

Vestal Point Capital’s Abivax ABVX Stock Holding History

Vestal Point Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167M Sell
1,500,000
-400,000
-21% -$47.3M 4.67% 3
2025
Q4 		$256M Buy
1,900,000
+900,000
+90% +$98.2M 8.71% 1
2025
Q3 		$84.9M Buy
+1,000,000
New +$61.3M 3.83% 4

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Vestal Point Capital's ABVX Position: Q1 2026 in Review

Vestal Point Capital reduced its Abivax (ABVX) stake by 21% in Q1 2026, selling an estimated $47.3M and leaving 1,500,000 shares worth $167M. The position accounts for 4.67% of the portfolio, ranked #3.

Vestal Point Capital first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. The position peaked at $256M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Vestal Point Capital held 1,500,000 shares of Abivax worth $167M as of Q1 2026.
  • Vestal Point Capital sold 400,000 Abivax shares in Q1 2026, an estimated $47.3M.
  • Abivax made up 4.67% of Vestal Point Capital's portfolio in Q1 2026, its #3 holding.
  • Vestal Point Capital first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • Vestal Point Capital's Abivax position peaked at $256M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.